GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cgh.2022.10.032
PubMed Identifier: 36343847
Publication URI: http://europepmc.org/abstract/MED/36343847
Type: Journal Article/Review
Volume: 21
Parent Publication: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Issue: 7
ISSN: 1542-3565